Cerner Corp (CERN) Reports In-Line Q3 EPS; Guides In-Line

October 24, 2013 4:03 PM EDT Send to a Friend
Cerner Corp (NASDAQ: CERN) reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $727.8 million versus the consensus estimate of $757.2 million.

Cerner Corp sees Q4 2013 EPS of $0.38-$0.39, versus the consensus of $0.39. Cerner Corp sees Q4 2013 revenue of $775-815 million, versus the consensus of $815.8 million.

"In addition to our solid financial results, our third quarter included several very strategic client wins across the globe and major development and deployment milestones for our population health and mobility solutions," Neal Patterson, Cerner chairman, CEO and co-founder said. "Cerner sits at the intersection of health care and information technology, and I really like that intersection. Trends in health care costs are unsustainable and IT is the only remaining lever to pull that can change the current trajectory. Cerner has done well and we believe will continue to do well in the current electronic medical record era, but it's our investments in capabilities beyond the EMR that differentiate us from our current competitors and position us for sustained growth through the decade."

For earnings history and earnings-related data on Cerner Corp (CERN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment